Supplementary Figure 1 . RNAi knockdown of FLAM3 causes a reduction in eYFP::FLAM3 expression without expression of the epimastigote marker, BARP. A) ) estern blot using the anti-GFP antibody of SMOXP9 eYFP::FLAM3 FLAM3 RNAi-A cells during a FLAM3 RNAi induction time course. Ponceau staining is a loading control. 4 x 106 cell equivalents were loaded per lane. B) ) estern blot using the anti-BARP antibody of a 29-13 cell line carrying a doxycycline inducible BARP expression plasmid before and after 24 hours of induction and of the SMOXP9 eYFP::FLAM3 RNAi-A before and after 72 hours of induction. The anti-PFR antibody was used as a loading control. 5 mM bathophenanthroline disulfonic acid, a metalloprotease inhibitor, was added to cultures to be analysed for BARP expression 20 hours before harvesting. C) ) Immunofluorescence of 29-13 cell line carrying a doxycycline inducible BA expression plasmid before and after 24 hours of induction and of the SMOXP9 eYFP::FLAM3 RNAi-A before and after 72 hours of induction.5 mM bathophenanthroline disulfonic acid, a metalloprotease inhibitor, was added to cultures to be analysed for BARP expression 20 hours before harvesting. Scale bar, 5 µm.
A) An initial complex of FLAM3 and ClpGM6 is formed, which is assembled into the growing FAZ. A later addition of FLAM3 then occurs with the protein integrating into the existing ClpGM6 FLAM3 complexes and any FLAM3 excess is distributed along the flagellum. B) ) On FLAM3 RNAi the complex is unable to form and is degraded, leading to reduced levels of ClpG expression. C) ) On ClpGM6 RNAi the complex is unable to form and is degraded, leading to a reduction in FLAM3 The loss of ClpGM6 does not effect the later addition of FLAM3 to the flagellum.
